ethylnitrosourea has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morales, C; Vaquero, J; Zurita, M | 1 |
| Kiran, AVVVR; Krishnamurthy, PT; Kumari, GK | 1 |
2 other study(ies) available for ethylnitrosourea and paclitaxel
| Article | Year |
|---|---|
Growth-inhibiting effects of intralesional docetaxel and paclitaxel on an experimental model of malignant neuroectodermal tumor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Division; Docetaxel; Ethylnitrosourea; Immunoenzyme Techniques; Injections, Intralesional; Models, Animal; Neoplasms, Experimental; Neuroectodermal Tumors; Paclitaxel; Rats; Rats, Wistar; Taxoids; Time Factors | 2002 |
Preliminary evaluation on the beneficial effects of pioglitazone in the treatment of endometrial cancer.
Topics: Animals; Antineoplastic Agents; Body Weight; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Endometrial Neoplasms; Estradiol; Ethylnitrosourea; Female; Mice; Paclitaxel; Pioglitazone; Survival Rate; Uterus | 2021 |